全球动脉粥样硬化切除系统市场 - 行业趋势和 2029 年预测

市场分析和规模

动脉粥样硬化切除术设备用于去除动脉中的斑块和血栓。外周动脉和冠状动脉的动脉粥样硬化可以用动脉粥样硬化切除术系统治疗。斑块或血栓在动脉中积聚，阻碍血液自由流动。因此，为了加快工作流程，患者必须接受动脉粥样硬化切除术，这就需要采用动脉粥样硬化切除术技术。

与机械系统相比，该系统具有多种优势，例如适应性、可操作性提高以及无需使用栓塞保护装置，这些优势有望推动市场收入。Data Bridge Market Research 分析称，2021 年动脉粥样硬化切除系统市场价值为 5.255 亿美元，预计到 2029 年将达到 9.4998 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 6.80%。

报告范围和市场细分

Market Definition

Plaque and thrombus are removed from the arteries using atherectomy equipment. The atherectomy systems are used to treat disorders of the peripheral and coronary arteries. The buildup of plaque or thrombus in the arteries prevents blood from flowing freely. As a result, a patient must undergo atherectomy to streamline the workflow, necessitating the use of atherectomy technologies.

Physical Therapy Market Dynamics

Drivers

• Rise in the preference for minimally invasive procedure

The gadgets are in high demand because to the growing trend of minimally invasive surgeries, which do less damage to the body than traditional medical procedures.

• Increase in the target patient population

Growing number of geriatric residents around the world. According to the National Health and Nutrition Examination Survey, around 6% of adults over the age of 40 have PAD, which translates to approximately 7 million patients in the United States alone and nearly 200 million worldwide.

• Technological developments

Advances in endovascular technology have made it possible to handle peripheral and coronary vascular disorders with a minimally invasive percutaneous approach in the majority of patients who previously required an invasive procedure.

Opportunities

In addition, the growing incidence of peripheral arterial diseases are further estimated to provide potential opportunities for the growth of the atherectomy systems market in the coming years.

Restraints/Challenges

On the other hand, the strict regulations and increased cost of the product is further projected to impede the growth of the atherectomy systems market in the targeted period. However, the dearth of skilled healthcare professionals might further challenge the growth of the atherectomy systems market in the near future.

This atherectomy systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the atherectomy systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Atherectomy Systems Market

The COVID-19 had a negative impact on the atherectomy systems market. During the epidemic, social isolation and limitations severely impacted businesses and activities, causing transportation and logistical problems around the world. Due to the rapid emergence of the COVID-19 pandemic, several elective cardiovascular procedures were cancelled or postponed to reduce the risk of coronavirus infection during hospital visits. Furthermore, supply effects were exacerbated by lower discretionary income. However, once the epidemic is gone, there is a beneficial impact on the market.

Recent Development

• Cardiovascular Systems, Inc. gained CE Mark for the Diamondback 360 Coronary Orbital Atherectomy System in January 2021. (OAS). The device has GlideAssist, which allows for better device tracking, repositioning, and removal, especially during difficult procedures, and may be used to treat a variety of calcium modalities. The company's product portfolio will be expanded as a result of the strategic move.

Global Atherectomy Systems Market Scope and Market Size

The atherectomy systems market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Directional Atherectomy
• Orbital Atherectomy
• Photo-Ablative (Laser) Atherectomy
• Rotational Atherectomy
• Support Devices

On the basis of product, the atherectomy systems market is segmented into directional atherectomy, orbital atherectomy, photo-ablative (laser) atherectomy, rotational atherectomy, support devices and others.

Application

• Peripheral Vascular
• Cardiovascular
• Neurovascular
• Others

On the basis of application, the atherectomy systems market is segmented into peripheral vascular, cardiovascular, neurovascular and others.

End User

• Hospitals and Surgical Centres
• Ambulatory Care Centres
• Research Laboratories
• Academic Institutes
• Others

On the basis of end user, the atherectomy systems market is segmented into hospitals and surgical centres, ambulatory care centres, research laboratories and academic institutes and others.

Atherectomy Systems Market Regional Analysis/Insights

The atherectomy systems market is analysed and market size insights and trends are provided by country, product, application and end user as referenced above.

The countries covered in the atherectomy systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the atherectomy systems market due to the rise in the expenditure for research and development. Furthermore, the growing incidence of cardiovascular diseases will further boost the growth of the atherectomy systems market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth during the forecast period of 2022 to 2029 due to the rise in the patient awareness. Moreover, the enhancing healthcare infrastructure is further anticipated to propel the growth of the atherectomy systems market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The atherectomy systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for atherectomy systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the atherectomy systems market. The data is available for historic period 2010-2020.

Competitive Landscape and Atherectomy Systems Market Share Analysis

The atherectomy systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to atherectomy systems market.

动脉粥样硬化切除系统市场的一些主要参与者包括

• BD（美国）
• 美敦力（爱尔兰）
• Koninklijke Philips NV（荷兰）
• 卡地纳健康公司（Cardinal Health）。（美国）
• 心血管系统公司（美国）
• 波士顿科学公司 (美国)
• Minnetronix Medical Inc.（美国）
• Avinger。（美国）
• Straub Medical AG（瑞士）
• Biomerics。（美国）
• Biotronik（德国）
• Ra Medical Systems（美国）
• 泰尔茂株式会社 (日本)
• 雅培（美国）
• B.Braun Melsungen AG（德国）
• Covidien（爱尔兰）
• Spectranetics（美国）
• 百特（美国）
• 拜耳公司（德国）
• Getinge AB（瑞典）

SKU-25272